<p><em>新的白皮书强调健康老龄化、女性健康和代谢健康如何通过科学支持的个性化和数字化营养补充解决方案重塑预防营养的未来</em></p>
<p>, /PRNewswire/ -- 随着全球医疗保健优先事项从反应性治疗转向主动健康和预防，营养补充品行业出现了新的增长机会。</p>
<p>在其最新的白皮书《营养补充品中的健康经济：健康老龄化、女性健康成分和体重管理的增长机会》中，Frost &amp; Sullivan 探讨了人口结构变化、代谢健康挑战和对个性化营养需求上升如何重塑行业的未来。</p>
<p>白皮书强调，消费者、医疗保健生态系统和成分创新者越来越多地围绕 “健康寿命” 这一概念聚集——延长健康生活的年限，而不仅仅是延长寿命。到 2030 年，全球每六个人中就有一个将年满 60 岁，而到 2035 年，全球超过 50% 的人口预计将超重或肥胖，从而加大对以预防为导向的营养解决方案的需求。</p>
<p>“传统的老龄化模型专注于疾病管理而非预防，正在迅速被重新定义，” Frost &amp; Sullivan 的化学、材料与营养顾问 Véronique Scordia 表示。</p>
<p>“下一个增长阶段将由整合的、科学支持的解决方案主导，这些解决方案不仅延长寿命，还延长健康寿命。那些结合营养、生物技术和个性化健康洞察，以应对移动性、认知和代谢韧性的公司将塑造健康老龄化和长寿的未来。”</p>
<p>研究确定了三个高增长领域正在改变营养补充品的格局：健康老龄化、体重管理和女性健康。</p>
<p>体重管理正在超越传统的卡路里减少策略，向更广泛的代谢健康优化发展。报告指出，GLP-1 驱动的创新正在重塑制药和营养补充品行业，为专注于食欲控制、饱腹感、能量调节和可持续长期健康的解决方案创造新的机会。</p>
<p>“随着 GLP-1 通路的获得关注，体重管理正进入一个新的生物驱动解决方案时代，” Frost &amp; Sullivan 的化学、材料与营养行业分析师 Akheela Dhiman 指出。</p>
<p>“重点正在从短期结果转向持久的整体健康，创造医疗保健与食品和成分行业之间的新交集。”</p>
<p>白皮书还强调女性健康是行业中最具战略意义的增长机会之一，这一机会源于对历史上被忽视和研究不足的健康需求的日益关注，包括生育、激素健康、更年期和代谢健康。</p>
<p>“女性健康市场正在经历结构性重置，” Frost &amp; Sullivan 的化学、材料与营养行业分析师 Nimisha Dhomne 表示。</p>
<p>“生命周期营养、基于生物标志物的洞察和经过验证的成分正在重塑创新优先事项，重点越来越多地放在精准性、可信度和为真实生理复杂性设计的解决方案上。”</p>
<p>Frost &amp; Sullivan 确定了几个塑造营养补充品未来的战略要素，包括微生物组科学的进展、生物活性成分、个性化递送系统、数字健康整合和直销模式。报告还强调了围绕围绝经期营养、多功能健康老龄化解决方案以及在快速增长的亚太和拉丁美洲市场扩大营养补充品获取的新的增长机会。</p>
<p>报告中介绍的领先创新者包括 dsm-firmenich、Novonesis、Glanbia Nutritionals 和 Nestlé Health Science，它们因推动成分创新、微生物组科学、代谢健康和生命周期营养解决方案而受到认可。</p>
<p>要索取《营养补充品中的健康经济：健康老龄化、女性健康成分和体重管理的增长机会》的免费副本，请点击这里。</p>
<p><strong>关于 Frost &amp; Sullivan</strong></p>
<p>Frost &amp; Sullivan，转型增长公司，帮助客户加速增长，实现增长、创新和领导力方面的最佳表现。公司的增长管道即服务为首席执行官的增长团队提供转型战略和最佳实践模型，以推动强大增长机会的生成、评估和实施。超过 60 年来，Frost &amp; Sullivan 与投资者、企业领导者和政府合作，识别、优先考虑和执行转型增长战略。</p>
<p>Kristina Menzefricke</p>
<p>市场与传播</p>
<p>全球客户体验</p>
<p>[email protected]</p>
<p>来源 Frost &amp; Sullivan</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTEzJk5ld3NJdGVtSWQ9REE1ODY4NyZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MTMxNTM1UFJfTkVXU19VU1BSX19fX19EQTU4Njg3?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTEzJk5ld3NJdGVtSWQ9REE1ODY4NyZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MTMxNTM1UFJfTkVXU19VU1BSX19fX19EQTU4Njg3"/></p>

雀巢(ADR)

雀巢

日常消费品 ETF - Vanguard

<p>Frost & Sullivan 的新白皮书探讨了营养保健品中 “健康经济” 的崛起，强调了在健康老龄化、女性健康和体重管理方面的增长机会。随着医疗保健向主动健康管理转变，个性化营养的需求正在增加。主要趋势包括体重管理策略的演变和对女性健康需求的关注。报告确定了战略要务，如微生物组科学和数字健康整合，领先的创新者如 dsm-firmenich 和雀巢健康科学正在塑造行业的未来</p>

<p><em>New whitepaper highlights how healthy aging, women's health, and metabolic wellness are reshaping the future of preventive nutrition through science-backed, personalised, and digitally enabled nutraceutical solutions</em></p>
<div class="lb-trans"><p><em>新的白皮书强调健康老龄化、女性健康和代谢健康如何通过科学支持的个性化和数字化营养补充解决方案重塑预防营养的未来</em></p>
</div><p>, /PRNewswire/ -- As global healthcare priorities shift from reactive treatment toward proactive wellness and prevention, new growth opportunities are emerging across the nutraceuticals industry.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- 随着全球医疗保健优先事项从反应性治疗转向主动健康和预防，营养补充品行业出现了新的增长机会。</p>
</div><p>In its latest whitepaper, The Healthspan Economy in Nutraceuticals: Growth Opportunities in Healthy Aging, Women's Health Ingredients, and Weight Management, Frost &amp; Sullivan explores how demographic shifts, metabolic health challenges, and rising demand for personalized nutrition are reshaping the future of the industry.</p>
<div class="lb-trans"><p>在其最新的白皮书《营养补充品中的健康经济：健康老龄化、女性健康成分和体重管理的增长机会》中，Frost &amp; Sullivan 探讨了人口结构变化、代谢健康挑战和对个性化营养需求上升如何重塑行业的未来。</p>
</div><p>The whitepaper highlights how consumers, healthcare ecosystems, and ingredient innovators are increasingly converging around the concept of &#34;healthspan&#34; - extending the number of years lived in good health rather than simply increasing lifespan. By 2030, one in six people globally will be aged 60 or older, while more than 50% of the global population is projected to be overweight or obese by 2035, intensifying demand for preventive, nutrition-led solutions.</p>
<div class="lb-trans"><p>白皮书强调，消费者、医疗保健生态系统和成分创新者越来越多地围绕 “健康寿命” 这一概念聚集——延长健康生活的年限，而不仅仅是延长寿命。到 2030 年，全球每六个人中就有一个将年满 60 岁，而到 2035 年，全球超过 50% 的人口预计将超重或肥胖，从而加大对以预防为导向的营养解决方案的需求。</p>
</div><p>&#34;The traditional model of aging focused on disease management rather than prevention is rapidly being redefined,&#34; said Véronique Scordia, Chemicals, Materials, &amp; Nutrition Consultant at Frost &amp; Sullivan.</p>
<div class="lb-trans"><p>“传统的老龄化模型专注于疾病管理而非预防，正在迅速被重新定义，” Frost &amp; Sullivan 的化学、材料与营养顾问 Véronique Scordia 表示。</p>
</div><p>&#34;The next phase of growth will be led by integrated, science-backed solutions that extend healthspan, not just lifespan. Companies that combine nutrition, biotechnology, and personalised health insights to address mobility, cognition, and metabolic resilience will shape the future of healthy aging and longevity.&#34;</p>
<div class="lb-trans"><p>“下一个增长阶段将由整合的、科学支持的解决方案主导，这些解决方案不仅延长寿命，还延长健康寿命。那些结合营养、生物技术和个性化健康洞察，以应对移动性、认知和代谢韧性的公司将塑造健康老龄化和长寿的未来。”</p>
</div><p>The research identifies three high-growth segments transforming the nutraceutical landscape: healthy aging, weight management, and women's health.</p>
<div class="lb-trans"><p>研究确定了三个高增长领域正在改变营养补充品的格局：健康老龄化、体重管理和女性健康。</p>
</div><p>Weight management is evolving beyond traditional calorie reduction strategies toward broader metabolic health optimisation. The report notes that GLP-1-driven innovation is reshaping both the pharmaceutical and nutraceutical industries, creating new opportunities for solutions focused on appetite control, satiety, energy regulation, and sustainable long-term wellness.</p>
<div class="lb-trans"><p>体重管理正在超越传统的卡路里减少策略，向更广泛的代谢健康优化发展。报告指出，GLP-1 驱动的创新正在重塑制药和营养补充品行业，为专注于食欲控制、饱腹感、能量调节和可持续长期健康的解决方案创造新的机会。</p>
</div><p>&#34;As GLP-1 pathways gain traction, weight management is entering a new era of biology-driven solutions,&#34; noted Akheela Dhiman, Industry Analyst, Chemicals, Materials, &amp; Nutrition at Frost &amp; Sullivan.</p>
<div class="lb-trans"><p>“随着 GLP-1 通路的获得关注，体重管理正进入一个新的生物驱动解决方案时代，” Frost &amp; Sullivan 的化学、材料与营养行业分析师 Akheela Dhiman 指出。</p>
</div><p>&#34;The emphasis is shifting from short-term results to lasting, holistic well-being, creating new intersections between healthcare and the food and ingredients industry.&#34;</p>
<div class="lb-trans"><p>“重点正在从短期结果转向持久的整体健康，创造医疗保健与食品和成分行业之间的新交集。”</p>
</div><p>The whitepaper also highlights women's health as one of the industry's most strategically significant growth opportunities, driven by increasing awareness of historically underserved and under-researched health needs spanning fertility, hormonal health, menopause, and metabolic wellness.</p>
<div class="lb-trans"><p>白皮书还强调女性健康是行业中最具战略意义的增长机会之一，这一机会源于对历史上被忽视和研究不足的健康需求的日益关注，包括生育、激素健康、更年期和代谢健康。</p>
</div><p>&#34;The women's health market is undergoing a structural reset,&#34; according to Nimisha Dhomne, Industry Analyst, Chemicals, Materials, &amp; Nutrition at Frost &amp; Sullivan.</p>
<div class="lb-trans"><p>“女性健康市场正在经历结构性重置，” Frost &amp; Sullivan 的化学、材料与营养行业分析师 Nimisha Dhomne 表示。</p>
</div><p>&#34;Life-stage nutrition, biomarker-led insights, and validated ingredients are reshaping innovation priorities, with the emphasis increasingly on precision, credibility, and solutions designed for real physiological complexity.&#34;</p>
<div class="lb-trans"><p>“生命周期营养、基于生物标志物的洞察和经过验证的成分正在重塑创新优先事项，重点越来越多地放在精准性、可信度和为真实生理复杂性设计的解决方案上。”</p>
</div><p>Frost &amp; Sullivan identifies several strategic imperatives shaping the future of nutraceuticals, including advances in microbiome science, bioactive ingredients, personalized delivery systems, digital health integration, and direct-to-consumer business models. The report also highlights emerging growth opportunities in perimenopause nutrition, multi-functional healthy aging solutions, and expanding access to nutraceuticals across rapidly growing APAC and Latin American markets.</p>
<div class="lb-trans"><p>Frost &amp; Sullivan 确定了几个塑造营养补充品未来的战略要素，包括微生物组科学的进展、生物活性成分、个性化递送系统、数字健康整合和直销模式。报告还强调了围绕围绝经期营养、多功能健康老龄化解决方案以及在快速增长的亚太和拉丁美洲市场扩大营养补充品获取的新的增长机会。</p>
</div><p>Leading innovators profiled in the report include dsm-firmenich, Novonesis, Glanbia Nutritionals and Nestlé Health Science, each recognised for advancing ingredient innovation, microbiome science, metabolic health, and life-stage nutrition solutions.</p>
<div class="lb-trans"><p>报告中介绍的领先创新者包括 dsm-firmenich、Novonesis、Glanbia Nutritionals 和 Nestlé Health Science，它们因推动成分创新、微生物组科学、代谢健康和生命周期营养解决方案而受到认可。</p>
</div><p>To claim your complimentary copy of &#34;The Healthspan Economy in Nutraceuticals: Growth Opportunities in Healthy Aging, Women's Health Ingredients, and Weight Management&#34;, click here.</p>
<div class="lb-trans"><p>要索取《营养补充品中的健康经济：健康老龄化、女性健康成分和体重管理的增长机会》的免费副本，请点击这里。</p>
</div><p><strong>About Frost &amp; Sullivan</strong></p>
<div class="lb-trans"><p><strong>关于 Frost &amp; Sullivan</strong></p>
</div><p>Frost &amp; Sullivan, the Transformational Growth Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation, and leadership. The company's Growth Pipeline as a Service provides the CEO's Growth Team with transformational strategies and best-practice models to drive the generation, evaluation, and implementation of powerful growth opportunities. For over 60 years, Frost &amp; Sullivan has partnered with investors, corporate leaders, and governments to identify, prioritise, and execute transformational growth strategies.</p>
<div class="lb-trans"><p>Frost &amp; Sullivan，转型增长公司，帮助客户加速增长，实现增长、创新和领导力方面的最佳表现。公司的增长管道即服务为首席执行官的增长团队提供转型战略和最佳实践模型，以推动强大增长机会的生成、评估和实施。超过 60 年来，Frost &amp; Sullivan 与投资者、企业领导者和政府合作，识别、优先考虑和执行转型增长战略。</p>
</div><p>Kristina Menzefricke</p>
<div class="lb-trans"><p>Kristina Menzefricke</p>
</div><p>Marketing &amp; Communications</p>
<div class="lb-trans"><p>市场与传播</p>
</div><p>Global Customer Experience</p>
<div class="lb-trans"><p>全球客户体验</p>
</div><p>[email protected]</p>
<div class="lb-trans"><p>[email protected]</p>
</div><p>SOURCE Frost &amp; Sullivan</p>
<div class="lb-trans"><p>来源 Frost &amp; Sullivan</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTEzJk5ld3NJdGVtSWQ9REE1ODY4NyZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MTMxNTM1UFJfTkVXU19VU1BSX19fX19EQTU4Njg3" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=DA58687&amp;Transmission_Id=202605131535PR_NEWS_USPR_____DA58687&amp;DateId=20260513"/></p>

15:35 ETFrost & Sullivan Explores the Rise of the "Healthspan Economy" and Emerging Growth Opportunities in Nutraceuticals

prnewswire

纳斯达克生物科技指数 ETF - iShares Nasdaq

标普生物技术 3 倍做多 - Direxion

标普生物技术 ETF - SPDR

动态生物技术与基因组 ETF - Invesco

日常消费品 ETF - SPDR

纽交所高增长板生物技术指数 ETF - First Trust

医药突破 ETF - ALPS

2 倍做多纳斯达克生物技术 ETF - ProShares

美国消费品 ETF - iShares

生物科技 ETF - VanEck Vectors

Frost & Sullivan 探讨 “健康寿命经济” 的兴起以及营养补充剂领域的新兴增长机遇